Index 919
Clinician-Rated Dimensions of Psychosis 
Symptom Severity, 742–744
frequency of use of, 742
scoring and interpretation of, 742
WHO Disability Assessment Schedule 
(WHODAS), 16, 21, 734, 745–748
Ataque de nervios,  14, 211–212, 233, 833
Attention-deficit/hyperactivity disorder 
(ADHD), 11, 32, 59–66
associated features supporting diagnosis of, 61
comorbidity with, 65
culture-related diagnostic issues in, 62
development and course of, 61
diagnostic criteria for, 59–61
diagnostic features of, 61
differential diagnosis of, 63–65
functional consequences of, 63
gender-related diagnostic issues in, 63
medication-induced symptoms of, 65
other specified attentio n-deficit/hyperactivity 
disorder, 65–66
prevalence of, 61
risk and prognostic factors for, 62
unspecified attention- deficit/hyperactivity 
disorder, 66
Attenuated psychosis syndrome, 122, 783–786
associated features supporting diagnosis of, 784
comorbidity with, 786
development and course of, 785
diagnostic features of, 783–784
differential diagnosis of, 785–786
functional consequences of, 785
prevalence of, 784–785
proposed criteria for, 783
risk and prognostic factors for, 785
Autism spectrum disorder, 31–32, 50–59
associated features supporting diagnosis of, 55
comorbidity with, 58–59
culture-related diagnostic issues in, 57
development and course of, 55–56